|
⚲
|
| Keyboard |
| Rachel Humphrey | |
|---|---|
| Firm | |
| Address | c/o Normunity Holding Company, LLC One Beacon Street, 15th Floor Boston, MA 02108 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Normunity Holding Company LLC | 021-535143 | Executive Officer | 37.5 M of 75.0 M |
||
| Normunity Holding Company LLC | 021-429174 | Executive Officer | 45.9 M of 68.8 M |
||
| Xilio Therapeutics Inc | 021-390683 | Director | 95.0 M of 95.0 M |
||
| Xilio Therapeutics Inc | 021-387002 | Director | 50.2 M of 50.2 M |
||
| CytomX Therapeutics Inc | 021-242471 | Director | 70.0 M of 70.0 M |
||
| Methylgene Inc | 021-187365 | Executive Officer | 26.1 M of 35.5 M |
||
| Methylgene Inc | 021-158022 | Executive Officer | 35.6 M of 48.3 M |
||